Literature DB >> 16997709

Microparticle-based technologies for vaccines.

Derek T O'Hagan1, Manmohan Singh, Jeffrey B Ulmer.   

Abstract

Microparticles have been effectively used for many years as delivery systems for drugs and therapeutic proteins. Their application to the delivery of vaccines is not as extensive, but is growing. Utility has been demonstrated for the delivery of various types of vaccines (e.g., recombinant proteins, plasmid DNA, and peptides) and other vaccine components (e.g., immune potentiators). With respect to delivery of immune potentiators, synergistic effects are often observed whereby much more potent immune responses are induced with a combination than with either component alone. Hence, the prospects for broad application of microparticle-based delivery systems for vaccines are excellent.

Mesh:

Substances:

Year:  2006        PMID: 16997709     DOI: 10.1016/j.ymeth.2006.05.017

Source DB:  PubMed          Journal:  Methods        ISSN: 1046-2023            Impact factor:   3.608


  30 in total

1.  Blood stage merozoite surface protein conjugated to nanoparticles induce potent parasite inhibitory antibodies.

Authors:  Kae Pusic; Hengyi Xu; Andrew Stridiron; Zoraida Aguilar; Andrew Wang; George Hui
Journal:  Vaccine       Date:  2011-09-28       Impact factor: 3.641

Review 2.  Peptide/protein vaccine delivery system based on PLGA particles.

Authors:  Mojgan Allahyari; Elham Mohit
Journal:  Hum Vaccin Immunother       Date:  2016-03-03       Impact factor: 3.452

Review 3.  Proteomic contributions to our understanding of vaccine and immune responses.

Authors:  Allison C Galassie; Andrew J Link
Journal:  Proteomics Clin Appl       Date:  2015-09-10       Impact factor: 3.494

4.  Promoted transfection efficiency of pDNA polyplexes-loaded biodegradable microparticles containing acid-labile segments and galactose grafts.

Authors:  Zhu Chen; Xiaojun Cai; Ye Yang; Guannan Wu; Yaowen Liu; Fang Chen; Xiaohong Li
Journal:  Pharm Res       Date:  2011-09-01       Impact factor: 4.200

5.  Negatively charged liposomes show potent adjuvant activity when simply admixed with protein antigens.

Authors:  Nijaporn Yanasarn; Brian R Sloat; Zhengrong Cui
Journal:  Mol Pharm       Date:  2011-06-07       Impact factor: 4.939

Review 6.  Advances in immunotherapy delivery from implantable and injectable biomaterials.

Authors:  David G Leach; Simon Young; Jeffrey D Hartgerink
Journal:  Acta Biomater       Date:  2019-02-13       Impact factor: 8.947

7.  The effect of antigen encapsulation in chitosan particles on uptake, activation and presentation by antigen presenting cells.

Authors:  Bhanuprasanth Koppolu; David A Zaharoff
Journal:  Biomaterials       Date:  2012-12-27       Impact factor: 12.479

8.  Tuning innate immune activation by surface texturing of polymer microparticles: the role of shape in inflammasome activation.

Authors:  Christine A Vaine; Milan K Patel; Jintao Zhu; Eunji Lee; Robert W Finberg; Ryan C Hayward; Evelyn A Kurt-Jones
Journal:  J Immunol       Date:  2013-02-20       Impact factor: 5.422

9.  Spray-dried chitosan microparticles for cellular delivery of an antigenic protein: physico-chemical properties and cellular uptake by dendritic cells and macrophages.

Authors:  Chirasak Kusonwiriyawong; Vimolmas Lipipun; Nontima Vardhanabhuti; Qiang Zhang; Garnpimol C Ritthidej
Journal:  Pharm Res       Date:  2013-03-13       Impact factor: 4.200

Review 10.  DNA vaccines: ready for prime time?

Authors:  Michele A Kutzler; David B Weiner
Journal:  Nat Rev Genet       Date:  2008-10       Impact factor: 53.242

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.